Introduction. Donation after cardiac death (DCD) is recognized as an important source of allografts to bridge the growing disequilibrium between the number of donors and recipients. Current transplant experience with DCD organs has focused on the adult recipient population, however little is known about the pediatric recipient experience. While there is increasing acceptance of these grafts in adults, transplant centers appear reluctant to use these grafts in the pediatric population. Methods. We reviewed the United Network for Organ Sharing database from 1995-2005 to determine the national experience with pediatric recipients of DCD organs. Results. Among 4026 renal transplants performed in children 18 years and younger, 26 (0.6%) received a renal allograft from a DCD donor. Ten (38.5%) received kidney allografts from pediatric donors (ageՅ18) and 16 (61.5%) from adult donors (ageϾ18 years). Graft survival at one and five years was 82.5%, 74.3% for kidneys from DCD donors compared to 89.6%, 64.8% from brain dead donors (DBD) (Pϭ0.7). Among 4991 liver transplants, 19 (0.4%) were from DCD donors. Sixteen patients (84.2%) received livers from pediatric donors and three (15.8%) from adult donors. Graft survival at one and five years was 89.2%, 79.3% for livers from DCD, compared to 75.6%, 65.8% for DBD (Pϭ0.3). Conclusion. The use of DCD donors in the pediatric population is very limited; however graft survival is comparable to DBD grafts. Although pediatric centers may have been reluctant to utilize this donor source, this limited experience demonstrates that the select use of DCD organs can produce acceptable and durable graft survival in the pediatric population.
O ver the last several years a growing interest has been expressed in pursuing organ donors immediately after cessation of cardiac function, as a means to increase organ availability. A recent national conference, as well as the Organ Donation Breakthrough Collaborative initiated by the Health Resources and Services Administration (HRSA) has addressed the growing experience with this type of donor. Also termed a non-heart-beating donor or donation after cardiac death (DCD), these efforts have affirmed the potential to increase organ donation (1, 2) . The United Network for Organ Sharing (UNOS) data demonstrates the growing number of DCDs as a percentage of total organ donors. In 1995 1.1 percent of all deceased donors were categorized as DCD, which increased to 3.9 percent in 2004 (3) .
In concordance, the total number of organs transplanted from DCDs has also risen, particularly among kidney and liver allografts, with a growing interest in the use of DCDs for pancreas and lung transplantation (4, 5) . Short and long-term data with renal allografts demonstrate similar survival as organs from brain dead donors (DBD), although the incidence of delayed graft function is approximately twice that compared to DBD (6, 7) . Among liver recipients, allograft survival appears to be inferior to that from brain dead donors, although some centers have reported equivalent results. Among liver recipients there may be an increased incidence of primary non-function and biliary complications (8 -15) .
The data regarding outcomes has primarily been based upon transplantation in adults. With the renewed interest in DCDs, the question arose as to the experience and outcomes in the pediatric population. To address this issue a query of the UNOS database was undertaken.
METHODS
The UNOS renal and liver transplant databases were examined to define donor and recipient variables among those pediatric patients who had received an allograft from a DCD. The data was limited to the years 1995 through September 2005. Recipients 18 years or less at the time of transplant were included. Graft survival was defined as the time from transplant to last follow-up, retransplant, return to dialysis, or patient death. Those patients without follow-up or who were lost to follow-up were excluded. Among liver recip-ients, primary nonfunction was defined as graft failure within seven days of transplant. A comparison group consisted of all pediatric recipients of a cadaveric allograft.
Means of continuous variables were compared by ttests and categorical variables were compared by chi square testing. Kaplan-Meier analysis was used to compute overall graft and patient survival. Comparison of Kaplan-Meier survival between groups was performed using the log-rank statistic. Statistical analysis was performed with SPSS version 13 for Windows (SPSS Inc., Chicago, IL).
RESULTS

Kidney Transplants
During the period analyzed, 26 pediatric DCD kidney transplants took place compared to 4000 from DBDs (Table  1) . Donor characteristics including cold ischemic time were similar between the groups. Mean donor age was also similar; with 38.5 percent of the donors 18 years of age or less. Discharge creatinine and delayed graft function were similar to DCD recipients (Table 3 ). Five year graft survival was 74.3%, compared to 64.8% for DBD ( Figure 1 ).
Liver Transplants
There were 19 pediatric recipients identified who received DCD liver grafts. When compared to transplants from DBDs, there was a trend toward older recipient age (Pϭ0.09), however mean donor age was not significantly different. In contrast to the renal donors, 84.2% of the DCD grafts were from donors younger than 18 ( Table 2 ). The recipient's medical condition based upon the patient's location prior to transplant was similar between the two groups. Incidence of primary nonfunction and retransplant were similar between DCD and DBD recipients (Table 3 ). Five year graft survival was 79.3% for DCD livers compared to 65.8% for DBD (Fig. 1) .
DISCUSSION
Organ donation from DCD has gained considerable attention within the last few years, as the disparity between the waitlist and donors continues to grow. The potential to increase the number of donors from this source and ameliorate the organ shortage may be substantial. Previous reports have, in general, focused upon outcomes in the adult recipient population. The current analysis was conducted to ascertain the incidence and outcome with DCD organs in the pediatric population. The national experience during the last ten years is limited, with only 26 kidney recipients and 19 liver recipients; however, the outcomes appear to compare favorably to organs from DBD donors.
Transplantation of DCD organs has primarily been to the adult population, with this type of donor usually considered an expanded criteria donor. In general organ allocation tends to favor the pediatric recipient, and understandably there is a reluctance by the pediatric transplant surgeon and physician to transplant children with organs that might be considered less desirable and have poorer long-term survival. Although long-term renal data in the adult population demonstrates outcomes similar to that of DBDs, national data is not as favorable among liver recipients (6, 7) . Two analyses utilizing UNOS data demonstrate an approximately 10% lower graft survival among recipients of a DCD liver. Inferior graft survival persists after controlling for multiple donor and recipient variables (11, 14) . Among recipients of a liver transplant from a DCD, there may be an increased incidence in ischemic type biliary strictures as well as primary nonfunction (10) . The increased risk of poor graft function is balanced by the high rate of death on the adult waiting list for liver transplantation. Some single center reports have shown favorable outcomes with this type of donor, raising the possibility that donor selection, procurement technique, or short ischemic times could ameliorate untoward complications (9, 12, 13, 15) .
A majority of the DCD kidney donors in this analysis were young adults, utilized in older children. In comparison, most liver donors were children, likely related to the necessity of matching graft to recipient size in younger children with liver disease. Recently successful split liver transplantation from DCDs into children has been reported by the group at King's College (16, 17) .
The potential to increase the pediatric donor pool through the routine use of pediatric DCDs is attractive, but only if outcomes are also acceptable. Koogler examined this issue in a pediatric ICU, and found the potential for a 40% increase in pediatric donors (18) . Estimates as to the number of increased grafts if all potential DCDs were utilized vary widely, from 11 to 350% (19, 20) . The variability in these estimates is dependent on the consideration of uncontrolled DCD donors. However the true potential number of donors may fall on the lower side of this estimate. In the United States, experienced organ procurement organizations with long standing DCD programs report that about 20% of cadaveric donors fall into this category (3) . Given the small size of the population in this study it is difficult to draw solid conclusions. Pediatric recipients of DCD organs appear to have results similar to recipients of DBD organs, but caution should be urged with interpretation of the data. While the data does provide some insight into the pediatric population of DCD donors and recipients, it is not FIGURE 1. Graft survival among kidney (part A) and liver recipients (part B). Graft survival at one and five years among DCD kidney recipients was 82.5% and 74.3% vs. 89.6% and 64.8 for DBD (Pϭ0.7). For DCD liver recipients, one and five year graft survival was 89.2% and 79.3% vs. 75.6% and 65.8% for DBD (Pϭ0.3).
able to explore some clinically relevant sources of morbidity such as biliary strictures, due to the nature of large national datasets. Despite these limitations, and although transplant centers have understandably been reluctant to use DCD organs in pediatric patients, this data suggest that with selective use and in the correct setting, liver and kidney recipients can expect durable results. 
